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The type III effector protein encoded by avirulence gene B (AvrB)
is delivered into plant cells by pathogenic strains of Pseudomonas
syringae. There, it localizes to the plasma membrane and triggers
immunity mediated by the Arabidopsis coiled-coil (CC)-nucleotide
binding (NB)-leucine-rich repeat (LRR) disease resistance protein
RPM1. The sequence unrelated type III effector avirulence protein
encoded by avirulence gene Rpm1 (AvrRpm1) also activates RPM1.
AvrB contributes to virulence after delivery from P. syringae in
leaves of susceptible soybean plants, and AvrRpm1 does the same
in Arabidopsis rpm1 plants. Conditional overexpression of AvrB in
rpm1 plants results in leaf chlorosis. In a genetic screen for mutants
that lack AvrB-dependent chlorosis in an rpm1 background, we
isolated TAO1 (target of AvrB operation), which encodes a Toll-IL-1
receptor (TIR)-NB-LRR disease resistance protein. In rpm1 plants,
TAO1 function results in the expression of the pathogenesis-
related protein 1 (PR-1) gene, suggestive of a defense response. In
RPM1 plants, TAO1 contributes to disease resistance in response to
Pto (P. syringae pathovars tomato) DC3000(avrB), but not against
Pto DC3000(avrRpm1). The tao1–5 mutant allele, a stop mutation
in the LRR domain of TAO1, posttranscriptionally suppresses RPM1
accumulation. These data provide evidence of genetically separa-
ble disease resistance responses to AvrB and AvrRpm1 in Arabi-
dopsis. AvrB activates both RPM1, a CC-NB-LRR protein, and TAO1,
a TIR-NB-LRR protein. These NB-LRR proteins then act additively to
generate a full disease resistance response to P. syringae express-
ing this type III effector.
Exposure to pathogens has driven the evolution of a sophis-ticated plant immune system that controls complex defense
mechanisms for limiting infection (1). Plants express disease
resistance proteins whose activation results in the restriction of
pathogen growth and, typically, a localized cell death termed the
hypersensitive response (HR). The most common class of dis-
ease resistance proteins consists of a central nucleotide binding
(NB) site and a C-terminal leucine-rich repeat (LRR). NB-LRR
proteins can be further subdivided based on the presence of a
coiled-coil (CC) or a Drosophila Toll-IL-1 receptor (TIR) do-
main at the N terminus. In response to infection by Gram-
negative bacterial phytopathogens, specific NB-LRR proteins
are activated via recognition of a pathogen-encoded type III
effector protein. This recognition can occur in an indirect
manner, whereby type III effectors are perceived via their
modification of host target proteins. Hence, NB-LRR proteins
can survey the integrity of intracellular host proteins targeted by
type III effectors acting as virulence factors. When a particular
type III effector activates an NB-LRR protein, that type III
effector is defined as an ‘‘avirulence protein.’’ This interaction is
specific, in that a single allele of a NB-LRR gene is typically
responsible for mediating resistance to a pathogen isolate
expressing a particular type III effector (1).
One exception to this rule is provided by the Pseudomonas
syringae type III effector proteins avirulence gene B (AvrB) and
avirulence gene RPM1 (AvrRpm1); each can elicit disease
resistance mediated by the Arabidopsis CC-NB-LRR protein
RPM1 (2, 3). After their delivery into host cells by the type III
secretion pilus, AvrB and AvrRpm1 undergo N-terminal myris-
toylation that facilitates association with the plant plasma mem-
brane (4). Here, these type III effectors associate with the
membrane-bound host target protein, RIN4 (RPM1-interacting
protein 4) (5). AvrB-RIN4 or AvrRpm1-RIN4 interactions are
correlated with the phosphorylation of RIN4 and activation of
RPM1 (6). Interestingly, in Glycine max (soybean) resistance to
pathogen strains expressing AvrB or AvrRpm1 can be encoded
by two different CC-NB-LRR genes, Rpg1-b and Rpg1-r, respec-
tively (7, 8). Genetic data confirms that AvrB andAvrRpm1 have
multiple host targets in Arabidopsis rpm1 plants (9), suggesting
that different NB-LRR receptors may have evolved to monitor
the integrity of independent targets of these two type III
effectors. Yet, the ability of AvrRpm1 and AvrB to trigger
disease resistance in Arabidopsis has never been separated.
Transgenic in planta conditional expression of AvrB in rpm1
plants leads to leaf chlorosis (4). AvrB-induced chlorosis is
RIN4-independent (9), but requires the host protein RAR1
(required for Mla-resistance 1) (10). RAR1 is part of a chap-
erone complex that functions to positively regulate steady-state
accumulation of numerous NB-LRR proteins (9, 11–13). Addi-
tionally, RAR1 is a positive regulator of basal disease resistance
against virulent pathogens (13). Because AvrB can coimmuno-
precipitate RAR1, the suggestion has recently arisen that RAR1
might be a virulence target of AvrB (10).
We performed a genetic screen to isolate mutants compro-
mised for AvrB-induced chlorosis. This screen was performed in
Mt-0, an ecotype (inbred genetic line) of Arabidopsis from which
RPM1 is naturally deleted (14), but which responds to AvrB with
leaf chlorosis (4). We defined and isolated TAO1 (target of AvrB
operation), a gene encoding a disease resistance protein of the
TIR-NB-LRR class. TAO1 activation correlates with defense
gene expression. A specific mutant allele of TAO1 posttranscrip-
tionally suppresses the steady-state accumulation of RPM1. In
the Col-0 (RPM1) accession, TAO1 is required for a full resis-
tance response to P. syringae pathovars tomato (Pto)
DC3000(avrB) but not to Pto DC3000(avrRpm1), showing that
recognition of these two type III effectors is genetically sepa-
rable in Arabidopsis. TAO1-dependent phenotypes, like disease
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resistance mediated by all TIR-NB-LRR proteins, requires
phytoalexin deficient 4 (PAD4). Our data provide further evi-
dence that CC and TIR subclasses of NB-LRR proteins can
function additively in disease resistance responses against
biotrophic pathogens.
Results
TAO1 Encodes a TIR-NB-LRR Protein Required for AvrB-Induced Chlo-
rosis in rpm1 Host Plants.Wedesigned a conditional genetic screen
to isolate loci required for AvrB-induced chlorosis in Mt-0
(rpm1). A stable single insertion transgenic line carrying a
dexamethasone (DEX)-inducible avrB expression system [DEX-
:avrB-HA (15)] was established inMt-0 (seeMethods). Seed from
this line was mutagenized, and 400,000 M2 plants were
screened for loss of AvrB-induced chlorosis after DEX treat-
ment (Fig. 1A). DEX-inducible AvrB-HA expression was con-
firmed in mutant (fully green) M3 progeny by Western blot
analysis (Fig. 1B). We used transient Agrobacterium transforma-
tion of DEX:avrB-HA on several M3 progeny from each putative
M2 mutant plant to eliminate mutations in the DEX:avrB-HA
expression system. In this assay, plants mutated in the DEX:
avrB-HA transgene were complemented by the transient expres-
sion of DEX:avrB-HA and display chlorosis after DEX
treatment. These lines were not studied further.
Genetic complementation crosses indicated eight allelic, re-
cessive tao1 mutants that were also allelic to the naturally
occurring tao1 phenotype of Cvi-0 (4). TransgenicDEX:avrB-HA
rpm1 tao1–2 (Mt-0) and DEX:avrB-HA rpm1 tao1–5 (Mt-0) lines
were crossed independently to rpm1–3 TAO1 (Col-0) for map-
based cloning of TAO1. After DEX induction, F1 plants exhib-
ited host cell chlorosis, confirming that both tao1–2 and tao1–5
were recessive (data not shown). We isolated nonchlorotic plants
in the F2 generation. Two genotypes were present among these
nonchlorotic F2 plants: (i) those that lacked the DEX:avrB-HA
transgene and (ii) those that contained the DEX:avrB-HA trans-
gene and were homozygous tao1. We performed PCR with
avrB-specific primers to distinguish between these classes; plants
lacking the DEX:avrB-HA transgene were discarded. From the
tao1–5 cross, 1,000 informative F2 plants showed that TAO1
was tightly linked to the bottom of chromosome 5. In a smaller
F2 population, the tao1–2mutant allele also mapped to the same
location, which was in agreement with data previously presented
for the Cvi-0 loss of function allele of TAO1 (4). To avoid
mis-scoring caused by transgene silencing, we used transient
assays with Agrobacterium tumefaciens (DEX:avrB-HA) of F3
progeny to confirm the tao1 genotypes of F2 individuals. This
approach, combined with the sequence identification of muta-
tions in eight tao1 alleles (designated tao1–1 to tao1–8; Fig. 1C),
identified TAO1 as the Mt-0 allele of the Col-0 gene At5g44510.
TAO1 encodes a TIR-NB-LRR protein of the TNL-G clade
(16). There are no other NB-LRR genes at the TAO1 locus in the
reference Col-0 genome sequence. The deduced TAO1 protein
is only 26% similar to RPM1 and 25% similar to RPG1-B
(soybean). For further analyses, we chose three alleles: tao1–2,
an early stop mutation after Q36 and a likely null; tao1–1, a
missense mutation at G238E in the NB domain; and tao1–5, a
nonsense mutation atW892 that results in the deletion of the last
five LRRs (13 through 17) (Fig. 1C). Sequencing of the naturally
occurring tao1 allele in Cvi-0 revealed three amino acid changes
compared with the Mt-0 TAO1 sequence at 703, 781, and 957
(Fig. 1C). Col-0 TAO1 shares these amino acids with Mt-0, while
also having a polymorphism at amino acid 489.
TAO1 Activation Results in Expression of Pathogenesis-Related
Protein-1 (PR-1). We next evaluated whether TAO1 activation
resulted in expression of a common defense response gene,
PR-1. Five days after induction with DEX, DEX:avrB-HA rpm1
tao1–2 plants were nonchlorotic, whereas the DEX:avrB-HA
rpm1 TAO1 plants displayed strong leaf chlorosis (Fig. 2A).
TAO1-mediated chlorosis correlated with an increase in PR-1
expression in leaf tissue (Fig. 2A). Thus, TAO1 function results
in the induction of a common defense response marker. Similar
results were found for DEX:avrB-HA rpm1 tao1–5 (data not
shown).
To analyze TAO1 function in Col-0, a better-studied genetic
background for disease resistance studies thanMt-0, we used two
mutant alleles designated tao1–10 (SALK124245), and tao1–11
(SALK011670) that carry exon insertions in At5g44510 (Fig.
1D). Both are TAO1 transcript nulls [supporting information
(SI) Fig. S1]. These lines were crossed to an isogenic
DEX:avrB-HA rpm1–3 TAO1 line, and DEX:avrB-HA rpm1–3
tao1–10 and DEX:avrB-HA rpm1–3 tao1–11 lines were selected
from the resulting progeny. Five days after induction with DEX,
the DEX:avrB-HA rpm1–3 TAO1 plants were chlorotic, whereas
the DEX:avrB-HA rpm1–3 tao1–10 lines were nonresponsive
(Fig. 2B). Furthermore, TAO1 activation correlated with an
increase in PR-1 expression (Fig. 2B). Similar results were found
for DEX:avrB-HA rpm1–3 tao1–11 (data not shown). Hence,
tao1–10 and tao1–11 lose TAO1 function in response to AvrB
expression in planta.
RPM1 Function Is Lost Specifically in tao1–5. We next addressed
whether TAO1 contributes to RPM1-mediated disease resis-
tance. For this, we introduced an RPM1 transgene containing a
C-terminal myc epitope tag, expressed from the native RPM1
promoter (17), into Mt-0 (rpm1 TAO1). A line carrying a single
copy of the RPM1-myc transgene was selected and then crossed
Fig. 1. TAO1 is a TIR-NB-LRR R protein required for AvrB-induced chlorosis
in rpm1 host plants. (A) Mt-0 leaves were inoculated with Agrobacterium
containing T-DNA with a DEX:avrB-HA transgene (4). Leaves were treated
with DEX 48 h after inoculation. The picture was taken 72 h after inoculation.
(B) Western blot showing accumulation of AvrB-HA at 8 h after DEX treat-
ment. (C) Deduced structure of TAO1 alleles recovered in Mt-0 (red and black),
Col-0 Salk T-DNA insertion lines (blue), and as polymorphisms in Cvi-0 (purple).
For all missense mutations, the wild-type Mt-0 residue is listed first. TIR, amino
acids 42–172. NB, amino acids 197–492. LRR, amino acids 610-1122. All TAO1
alleles in Mt-0 were generated by EMS mutagenesis except tao1–8, which is a
fast neutron deletion of 1 bp in codon S667. Red tao1 alleles represent alleles
that were out-crossed away from the DEX:avrB-HA transgene and used for
further analyses. The tao1–10 (Salk124245) insertion begins at amino acid
168. The tao1–11 (Salk011670) insertion begins at amino acid 597. The only
amino acid difference between Mt-0 and Col-0 is V489M. Genomic TAO1
sequences for Mt-0 (EU031442) and Cvi-0 (EU031443) have been deposited in
GenBank.
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into the tao1–1, tao1–2, and tao1–5 mutant backgrounds (pre-
viously back-crossed and selected for loss of the DEX:avrB-HA
transgene) (see Methods). Stable RPM1-myc TAO1, RPM1-myc
tao1–1, RPM1-myc tao1–2, and RPM1-myc tao1–5 lines were
selected, and RPM1 function was assessed. After hand infiltra-
tion with Pto DC3000(avrB) or Pto DC3000(avrRpm1), RPM1
function resulted in only a 5- and 10-fold growth restriction of
bacteria, respectively (Fig. 3A), which is much less bacterial
growth restriction than observed in Col-0 (RPM1) (Fig. 4A). This
weak RPM1-mediated growth restriction is likely caused by
lower accumulation of RPM1-myc in Mt-0 relative to Col-0 (Fig.
S2). Lower RPM1-myc accumulationmay be the result of genetic
background differences between Mt-0 and Col-0 that control
RPM1 accumulation or transgene positional effects. In RPM1-
myc tao1–1 and RPM1-myc tao1–2, there was essentially no effect
on the weak RPM1-mediated growth restriction of Pto
DC3000(avrRpm1) or PtoDC3000(avrB) (Fig. 3A). Interestingly,
RPM1 function was lost in the RPM1-myc tao1–5 background in
response to either Pto DC3000(avrB) or Pto DC3000(avrRpm1)
(Fig. 3A).
RPM1Does Not Accumulate in the tao1–5 Background.Wepostulated
two possible reasons why RPM1 function is lost in the tao1–5
background. The tao1–5 mutant protein could either prevent
RPM1 signaling, or the tao1–5 mutant protein might negatively
regulate RPM1 steady-state accumulation. To distinguish be-
tween these possibilities, the RPM1-myc TAO1, RPM1-myc
tao1–1, RPM1-myc tao1–2, and RPM1-myc tao1–5 lines were
subjected to Western blot analysis for RPM1-myc. Despite some
experimental variation, RPM1 accumulated normally in RPM1-
myc tao1–1 and RPM1-myc tao1–2 (Fig. 3B). By contrast, RPM1
accumulation was abolished in RPM1-myc tao1–5 (Fig. 3B).
RT-PCR analysis revealed that this effect on RPM1 is posttran-
scriptional (Fig. S3). Interestingly, the effect of tao1–5 on RPM1
accumulation was recessive (Fig. 3C).
TAO1 Is Required for Full Disease Resistance Against Pto DC3000(avrB)
in Col-0.We introgressed the tao1–10 and tao1–11 null alleles into
rpm1–3. Homozygous rpm1–3 tao1–10 and rpm1–3 tao1–11 lines
were selected to evaluate TAO1 function in both the presence
and absence of RPM1. Interestingly, after dip inoculation in a
bacterial suspension of Pto DC3000(avrB), both the RPM1
tao1–10 and RPM1 tao1–11 lines displayed 10-fold less disease
resistance than RPM1 TAO1 (Fig. 4A). This effect of TAO1 was
not seen with hand infiltrations (data not shown), suggesting that
TAO1 may act early in pathogen infection. Hence, TAO1
contributes1–5% of the full resistance to PtoDC3000(avrB) in
the presence of RPM1. We observed no enhanced susceptibility
to PtoDC3000(avrB) in the rpm1–3 tao1–10 and rpm1–3 tao1–11
lines, indicating that the weak TAO1 contribution to disease
Fig. 2. TAO1 activation correlates with defense gene expression in both Mt-0 and Col-0. Five-week-old plants were sprayed with 20M Dex to induce expression
of AvrB-HA. (A) Mt-0 and tao1–2. (B) Col-0(rpm1–3) and rpm1–3 tao1–10. (Top) Photograph was taken 5 days after DEX treatment. (Middle) Western blot showing
PR-1 protein levels. (Bottom) Western blot analysis showing AvrB-HA protein levels. Equivalent amounts of total proteins were loaded in all lanes (data not
shown). The experiment is representative of three independent replicates.
Fig. 3. Weak RPM1 function in Mt-0 is suppressed posttranscriptionally by
tao1–5. (A) Four-week old plants were hand-infiltrated with PtoDC3000(avrB)
(Upper) or Pto DC3000(avrRpm1) (Lower) at 105 cfu/ml. Error bars represent
the SD among four samples. This experiment is indicative of three indepen-
dent replicates. Similar results were seen with dip infections (data not shown).
(B andC) Western blot analysis showing RPM1-myc accumulation in plant lines
with the noted genotypes. Cross-reacting band indicates equivalent amounts
of total protein loading. Samples from hybrid (F1) and parental (P1) lines are
noted above their respective genotypes. These experiments are indicative of
four (B) and two (C) independent replicates. The higher than wild-type level
of RPM-myc accumulation in the tao1–2 background shown in B was not
reproducible.










resistance is too low to measure in the absence of RPM1 (Fig.
4A). We observed full RPM1-mediated growth restriction in the
RPM1 tao1–10 and RPM1 tao1–11 lines after dip inoculation of
Pto DC3000(avrRpm1) (Fig. 4B). Hence, TAO1 contributes
specifically to disease resistance triggered by Pto DC3000(avrB)
and does not contribute to RPM1-mediated disease resistance in
response to Pto DC3000(avrRpm1). As with Pto DC3000(avrB),
we observed no enhanced susceptibility of the rpm1–3 tao1–10
and rpm1–3 tao1–11 lines to Pto DC3000(avrRpm1) (Fig. 4A).
Although RPM1-mediated resistance to Pto DC3000(avrRpm1)
was unaffected in the tao1–10 and tao1–11 lines, the possibility
existed that TAO1 affects RPM1 steady-state accumulation.
This scenario would indicate that different accumulation levels
of RPM1 are required for resistance to PtoDC3000(avrB) versus
Pto DC3000(avrRpm1). To address this possibility, the rpm1–3
tao1–10 and rpm1–3 tao1–11 lines were crossed to a rpm1–3
RPM1-myc TAO1 line (17). Stable rpm1–3 RPM1-myc tao1–10
and rpm1–3 RPM1-myc tao1–11 lines were selected.Western blot
analysis revealed that RPM1 accumulation was equivalent in the
tao1–10 and tao1–11 lines relative to the TAO1 parental line (Fig.
4B). Hence, loss of TAO1 does not affect RPM1 steady-state
accumulation. Therefore, the contribution of TAO1 to disease
resistance against PtoDC3000(avrB) in Col-0 is likely to be at the
signaling level.
TAO1 Requires PAD4 for Function. The Arabidopsis PAD4 protein
functions in both basal defense and TIR-NB-LRR-mediated
disease resistance (18, 19). To assess whether PAD4 is required
for TAO1 function, we crossed theDEX:avrB-HA rpm1–3 line to
the pad4–1mutant line (20) and selected homozygous F2 rpm1–3
pad4–1 lines that contained the DEX:avrB-HA transgene. After
inducing AvrB expression in planta, we observed that both
TAO1-mediated chlorosis and PR-1 expression were lost in the
rpm1–3 pad4–1 lines (Fig. S4A). Furthermore, inoculation with
Pto DC3000(avrB) and Pto DC3000(avrRpm1) on pad4–1 TAO1
RPM1 lines revealed that the TAO1 defense function against Pto
DC3000(avrB) is also lost in a pad4–1 mutant (Fig. S4B). Thus,
these results demonstrate that TAO1 requires PAD4 for
function.
Discussion
AvrB is a bacterial type III effector protein that causes modifi-
cation of the Arabidopsis host protein RIN4, subsequently
activating the NB-LRR protein RPM1 (5, 6, 21) or contributing
to pathogen virulence in susceptible plants (7). The sequence-
independent type III effector AvrRpm1 acts similarly (22). In the
absence of RPM1, in planta expression of AvrB produces a host
cell chlorosis originally speculated to be indicative of an AvrB
virulence function (4). Because AvrB-mediated chlorosis is
RIN4 independent, AvrBmust have additional targets within the
Arabidopsis cell (9). Our aims were to (i) identify host proteins
required for AvrB-induced chlorosis, (ii) assess whether and how
these host components affect RPM1 function triggered by either
AvrB or AvrRpm1, and (iii) clarify whether these host factors are
specific for the responses to AvrB. We identified only one gene
in our mutant screen, and it encodes TAO1, a TIR-NB-LRR
disease resistance protein.
Our data demonstrate that TAO1 activation contributes to
disease resistance in response to Pto DC3000(avrB), but not in
response to Pto DC3000(avrRpm1) (Fig. 4A). To explain the
functional relationship between AvrB, TAO1, and RPM1, we
propose the following model (Fig. S5). In rpm1 plants, TAO1
activation in response to AvrB is insufficient to cause a HR (data
not shown) or significantly restrict Pto DC3000(avrB) growth
(Fig. 4A). However, chlorosis and expression of a common
defense protein, PR-1, are induced (Fig. 2; see also Fig. S5 Left).
These data demonstrate that TAO1 is a weak disease resistance
protein that cannot create sufficient defense response amplitude
to restrict PtoDC3000(avrB) growth in the absence of RPM1. In
tao1 plants, RPM1 activation in response to AvrB results in a HR
in addition to a significant restriction of Pto DC3000(avrB)
growth (Fig. 4A) (Fig. S5 Center). Finally, the additive functions
of RPM1 and TAO1 facilitate full disease resistance to Pto
DC3000(avrB) (Fig. 4A) (Fig. S5 Right).
Because TAO1 function is RIN4 independent (9) and RIN4
is required for RPM1 function (5), TAO1 perception of AvrB
might occur at a cellular site that lacks RIN4 and RPM1.
Recently, two studies (6, 21) identified AvrB mutants that are
unable to activate RPM1, but still activate TAO1. For example,
the AvrB T125A mutation abolished both the RIN4–AvrB
interaction and the ability to trigger RPM1, but retained the
ability to activate TAO1 (6, 21). Additionally, the AvrB D297A
mutation retained interaction with RIN4 and lost RPM1 acti-
vation but still elicited TAO1 (6, 21). These data suggest that
there are likely to be structural differences in how AvrB targets
host proteins and consequently triggers either RPM1 or TAO1.
Despite the potentially separate mechanisms of TAO1 and
RPM1 activation, both require AvrB membrane localization via
myristoylation (4). These data may indicate that like RPM1 and
RIN4, a second putative protein(s), targeted by AvrB and
associated with TAO1, is also present at the plasma membrane.
Interestingly, the steady-state levels of RPM1 are significantly
diminished in tao1–5 (Fig. 3B). Because the other loss-of-
function mutant alleles tested, tao1–1 (presumptive P-loop dead)
and tao1–2 (presumptive null), do not affect RPM1 accumula-
tion and tao1–5 homozygosity is required for its effects on
RPM1, tao1–5 acts as a recessive gain-of-function allele (Fig. 3
B and C). This phenotype is reminiscent of the effects of specific
alleles of hsp90.2 on RPM1 accumulation (23, 24). The tao1–5
allele exhibits no other observable phenotypic defects (data not
shown). A tao1–5-encoded protein could sequester RPM1 di-
rectly or negatively affect RPM1 stability through its effects on
an intermediate host protein. Three host proteins shown to be
Fig. 4. TAO1 contributes to disease resistance against Pto DC3000(avrB) but
not Pto DC3000(avrRpm1). (A) Two- to 3-week-old plants were dip-infiltrated
with PtoDC3000(avrB) (Upper) or PtoDC3000(avrRpm1) (Lower) at a bacterial
concentration of 2.5  107 cfu/ml. Error bars represent the SD among four
samples. This experiment is representative of three independent replicates. (B)
Western blot analysis showing RPM1-myc accumulation in plant lines with the
noted genotypes. The cross-reacting band serves as an indicator of equivalent
amounts of total protein loaded. This experiment is representative of two
independent replicates.
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required for RPM1 steady-state accumulation are RIN4 and the
general NB-LRR chaperone complex members RAR1 and
HSP90.2 (5, 12). Because neither RPS2 function nor RPS5
steady-state accumulation are compromised in the tao1–5 back-
ground (data not shown), it is unlikely that the tao1–5 mutant
protein sequesters RIN4 or RAR1. Hence, we speculate that
HSP90.2 or an as-yet-undiscovered protein that contributes to
RPM1 steady-state accumulation is altered by the mutant
tao1–5-encoded product.
Recently, Shang et al. (10) demonstrated that RAR1 is
required for AvrB-dependent chlorosis in rpm1 plants (10). They
also showed that AvrB-induced chlorosis correlated with in-
creased growth of a Pto DC3000(hrpL) mutant that lacks the
type III pilus and therefore cannot deliver type III effectors to
the plant cell. This relaxation of basal defense responses was
RAR1 dependent. Also, when overexpressed, AvrB and RAR1
can be coimmunoprecipitated (10) and also allow reactivation of
a split-luciferase reporter (albeit under conditions where the
AvrB myristoylation site is buried in the reporter fusion and
mislocalization of AvrB is likely) (25). These results led the
authors to conclude that RAR1 is a ‘‘virulence target’’ of AvrB,
although no direct interaction of AvrB and RAR1 was demon-
strated (10). Our data demonstrate that AvrB-induced chlorosis
is mediated by the TIR-NB-LRR protein TAO1 and that TAO1
functions as a ‘‘weak R gene’’ (Figs. 2 and 4A). Thus, there is a
contradiction: is the observed host cell chlorosis indicative of
AvrB virulence targeting of RAR1, or does it represent a
TAO1-mediated disease resistance response, which in turn
requires RAR1?
There are several possible explanations for the differing
interpretations presented in ref. 10 and here regarding what
AvrB-mediated chlorosis represents. First, the increase in Pto
DC3000(hrpL) growth observed after induced AvrB overexpres-
sion in planta was COI1 dependent, whereas AvrB-induced
chlorosis was COI1 independent (10). Hence, our observation of
AvrB-mediated, TAO1-dependent chlorosis can be genetically
separated fromAvrB-mediated, COI1-dependent suppression of
basal defense (10). Second, our data show that AvrB-mediated
chlorosis requires the host protein PAD4 (Fig. S4), a positive
regulator of both basal defense and TIR-NB-LRR-mediated
disease resistance (18, 19). Third, a very strong regimen of
conditional overexpression of AvrB [30 M DEX spray 2 days
before the infection, and also continually throughout the Pto
DC3000(hrpL) infection] was used in ref. 10. Using a regimen of
two times 10MDEX treatment, but only 1 day before infection,
we were able to fully induce AvrB-dependent chlorosis in TAO1
plants, but did not observe increased growth of Pto
DC3000(hrcC) (data not shown). These data suggest that the
increased growth of PtoDC3000(hrpL) shown in ref. 10 is caused
by extraordinary levels of AvrB expression in planta, resulting in
extensive tissue collapse. Our data demonstrate that TAO1
contributes to the restriction of pathogen growth when AvrB is
delivered naturally via a type III pilus from Pto DC3000 (Fig.
4A). Furthermore, we note that using the same experimental
conditions as in ref. 10, it was shown that AvrB-mediated
chlorosis correlated with a growth reduction of PtoDC3000 (33).
This growth reduction was RAR1 dependent, consistent with a
role for NB-LRR proteins in basal defense (13), but difficult to
reconcile with the data presented in ref. 10. RAR1 regulates the
function of many NB-LRR proteins by acting as a positive
regulator of NB-LRR stability (9, 11–13). Hence, the simplest
scenario to explain the sum of the data presented here and in ref.
10 is that the loss of AvrB-dependent chlorosis in a rar1
background indicates that TAO1 requires RAR1 for steady-state
accumulation and therefore function.
The bacterial type III effector proteins AvrB and AvrRpm1
each trigger strong disease resistance through RPM1. Yet the
activation of TAO1 by AvrB suggests that additional layers of
recognition in response to infection can effectively add to the
plant’s defense response. In a mechanistic sense, if a given type
III effector has multiple cellular targets, then direct or indirect
recognition by more than one NB-LRR may add to both the
flexibility and the amplitude of the host’s overall response. These
scenarios provide hosts with greater evolutionary capacity, by
allowing NB-LRR proteins to continually fine-tune their re-
sponses to a single pathogen effector while maintaining an
intermediate level of disease resistance. This possibility may
explain recent examples of genetic requirements for combined
action of (i) a TIR-NB-LRR and a CC-NB-LRR protein (26) and
(ii) a TIR-NB-LRR and an atypical CC-containing NB-LRR
(27) against a virus and an isolate of the oomycete parasite
Hyaloperonospora parasitica, respectively. Our findings further
the concept that a CC-NB-LRR and a TIR-NB-LRR, which
typically trigger different response pathways in plants (28), can
additively contribute to disease resistance.
Methods
A. tumefaciens-Mediated, DEX-Inducible Transient Expression Assays. Transient
transformation assays were performed as described (4). Arabidopsis chlorosis
response in this assay was observed at 72 h after induction. Protein was
extracted 8 h after induction from four transformed leaf discs.
Generation of Stable Transgenic Lines, Mutagenesis, and Screening. Stable
transgenic plant lines were generated by the floral dip method (29). Segre-
gation of hygromycin resistance was used to isolate lines containing single-
copy insertions of both the DEX:avrB-HA (4) and RPM1-myc (17) transgenes in
Mt-0. For ethane methyl sulfonate (EMS) mutagenesis, 30,000 seeds were
incubated in a 0.25% EMS solution for 8 h, washed in distilled water, and dried
on filter paper. Fast neutron mutagenesis was performed by the International
Atomic Energy Agency research laboratory in Vienna, Austria. Approximately
700,000 M2 seeds in 100 lots (80 EMS, 20 fast neutron) were sprayed with 20
M DEX as described (30). Putative mutants were isolated and allowed to
self-pollinate. M3 progeny were retested byAgrobacterium transient delivery
of DEX:avrB-HA as described above.
Positional Cloning of TAO1 and Out-Crossing of the DEX:avrB-HA Transgene.
Mapping of TAO1 was performed as described (31). Candidate genes within
the TAO1 interval were PCR-amplified from the tao1 mutants, and PCR
products were sequenced directly. To obtain tao1 lines lacking the DEX-
:avrB-HA transgene, M3 tao1 lines were crossed to nontransgenic TAO1 Mt-0
plants. F2 plants containing the DEX:avrB-HA transgene were selected and
sprayed with 20M DEX. Nonchlorotic (tao1) lines were selected and allowed
to self-pollinate. F3 individuals that lacked the DEX:avrB-HA transgene were
selected and allowed to self-pollinate. F4 seed was confirmed for tao1 geno-
type byAgrobacterium transient transformation ofDEX:avrB-HA. Subsequent
confirmation of tao1 mutant alleles was performed by using dominant
cleaved amplified polymorphic sequences specific to the tao1 allele in
question.
Bacterial Infections. For Fig. 3A, 4-week-old plants were hand-infiltrated with
bacteria at a concentration of 105 cfu/ml. For each sample, four leaf disks were
pooled per time point (16 total). Leaf disks were ground in 10 mM MgCl2,
subject to serial dilutions, and plated on King’s Broth (KB) plates with rifam-
picin selection. For Fig. 4A and Fig. S4B, dip inoculations were performed as
described (32). Briefly, 2- to 3-week-old seedlings were inoculated by dipping
in solutions of bacteria at a concentration of 2.5 107 cfu/ml. Three seedlings
were placed in 1 ml of 10 mM MgCl2 with 0.2% Silwet L-77. The weights of the
tubes with seedlings were measured, and the tubes were then shaken for 1 h
at 28°C. Serial dilutions in 10 mM MgCl2 were made and plated on KB plates
with rifampicin selection.
Protein Analysis. For detection of AvrB-HA, PR-1, and RPM1-myc, total protein
extracts were prepared by grinding 200 mg of leaf tissue in buffer [50 mM
TrisHCl (pH 8.0), 1% SDS, 1 mM EDTA, 1 mM 2-mercaptoethanol, and plant
protease inhibitor mixture (Sigma)]. Protein concentrations were determined
by using the Bradford-Lowry method and quantification buffer from BioRad.
Ten microliters of 6 Laemmli buffer (final concentration 1) was added to all
measured samples after quantification. For immunodetection of AvrB-HA and
PR-1, 10-g protein samples were electrophoresed on 14% SDS polyacryl-
amide gels. For immunodetection of RPM1-myc, 40-g protein samples were
electrophoresed on 8% SDS polyacrylamide gels. Western blots were per-










formed by using standard methods. Anti-PR-1 serum (gift of Robert A. Di-
etrich, Syngenta, Research Triangle Park, NC) was used at a dilution of
1:10,000. The detection of the HA epitope tag was with supernatants from
cultures of hybridoma 3F10 monoclonal anti-HA antibody (Roche) at a dilution
of 1:1,000. Detection of the myc epitope tag was with supernatants from
hybridoma 9E10 monoclonal anti-myc antibody at a dilution of 1:10 (17).
RT-PCR. RNA was isolated from various plants lines by using TRIZOL Reagent
(GIBCO/BRL) according to the manufacturer’s instructions. RT-PCR (RETROscript;
Ambion) analysis in Fig. S1 and Fig. S3 was performed according to the manu-
facturer’s instructions. Plant 18S Competimer primers (Ambion) were used to
coamplify the 18S internal loading control. For Fig. S1, primers flanking the first
intronofTAO15-tatgaaatgcagagaagagttgg-3and3-ataaccgttctgctggtagag-5
were used with the PCR conditions 94°C 10 s, 55°C 60 s, 72°C 60 s, 31 cycles. A ratio
of 9:1 Competimer/18S was used. For Fig. S3, the RPM1 transcript primers 5-
caccatggcttcggctactgttgattttg-3 and 3-cactttgcatcgccatcatcaatagg-5 RPM1
transcriptprimerswereusedwiththePCRconditions94°C10s,55°C60s,72°C60s,
31 cycles. A ratio of 9.5:1 Competimer/18S was used. Products were separated on
a 1% agarose gel.
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